Arintra (YC W22) — Enterprise-grade AI for revenue assurance
Arintra is an enterprise AI platform for revenue assurance in healthcare, empowering health systems to get paid accurately, promptly, and fairly. Combining agentic AI with deep clinical expertise, Arintra autonomously codes every chart, explainably, across 23+ specialties and every care setting a health system operates — then cascades that intelligence across the revenue cycle through documentation intelligence (CDI) and denial appeals.
Arintra is a Y Combinator company in the Winter 2022 batch. Its directory entry describes it as: Enterprise-grade AI for revenue assurance. The founders listed are Nitesh Shroff, PhD (Founder), Preeti Bhargava, PhD (Founder) (Y Combinator directory entry, January 22, 2022).
Get an email when Arintra changes status, grows its team or files a funding notice. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
Arintra is an enterprise AI platform for revenue assurance in healthcare, empowering health systems to get paid accurately, promptly, and fairly. Combining agentic AI with deep clinical expertise, Arintra autonomously codes every chart, explainably, across 23+ specialties and every care setting a health system operates — then cascades that intelligence across the revenue cycle through documentation intelligence (CDI) and denial appeals. Leading enterprise health systems including UC Davis Health, Mercyhealth, Meritus Health, Rochester Regional Health, Reid Health, Mercy Medical Center, and more use Arintra as their centralized, audit-ready revenue cycle platform. Arintra is available in the Epic Toolbox and on the athenahealth Marketplace, is HITRUST e1 certified, and earned a 93/100 with A+ performance rating from KLAS Research.
Nitesh Shroff, PhD
Founder
Preeti Bhargava, PhD
Founder
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
One of 144 companies held here in Healthcare › Healthcare IT.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Want the whole picture on Arintra?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Arintra: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Arintra covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Arintra: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
